Coronary Endothelial Function Is Preserved With Chronic Endothelin Receptor Antagonism in Experimental Hypercholesterolemia in Vitro

Arteriosclerosis, Thrombosis, and Vascular Biology- United States

doi 10.1161/01.atv.19.11.2769

Full Text

Abstract

Available in

Categories

Cardiovascular Medicine

Date

November 1, 1999

Authors

Patricia J. M. Best

Lilach O. Lerman

Darcy Richardson

David R. Holmes

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction

Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiovascular Medicine

English

Chronic Selective Endothelin a Receptor Antagonism Reduces Serum Uric Acid in Hypertensive Chronic Kidney Disease

Internal Medicine

English

Attenuated in Vitro Coronary Arteriolar Vasorelaxation to Insulin-Like Growth Factor I in Experimental Hypercholesterolemia

Internal Medicine

English

Leptin Induces Endothelin-1 in Endothelial Cells in Vitro

Circulation Research

Cardiovascular Medicine

English

Folic Acid in Endothelial Function in Familial Hypercholesterolemia Response

Cardiovascular Medicine

English

Selective Loss of Microvascular Endothelial Function in Human Hypercholesterolemia

Cardiovascular Medicine

English

Endothelin Receptor a Antagonism Attenuates Renal Medullary Blood Flow Impairment in Endotoxemic Pigs

Multidisciplinary

English

Arrestin(g) Podocyte Injury With Endothelin Antagonism

Journal of the American Society of Nephrology : JASN

English

Endothelin Receptor Antagonism: A New Era in the Treatment of Pulmonary Arterial Hypertension

Advances in Pulmonary Hypertension

English